Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 8:53 AM UTC
| NCT Number | NCT05112601 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | PHASE2 |
| Target Enrollment | 81 participants |
| Active Locations | 137 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 14, 2026 (4 days ago) |
As of July 18, 2026: Clinical trial NCT05112601 is currently recruiting participants. This phase2 study for endometrial cancer is actively seeking new participants at 137 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05112601 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 137 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05112601 was last updated 4 days ago (July 14, 2026). HelloStudys verifies this status automatically.